T1	Participants 54 84	progressive Multiple Sclerosis
T2	Participants 282 332	patients with progressive multiple sclerosis (MS).
T3	Participants 882 912	a single centre (Bristol, UK).
T4	Participants 913 1085	Eighty patients with progressive MS will be recruited; 60 will have secondary progressive disease (SPMS) but a subset (n = 20) will have primary progressive disease (PPMS).
T5	Participants 2122 2137	progressive MS.
T6	Participants 2306 2317	MS patients
